154 related articles for article (PubMed ID: 36522255)
1. Botulinum toxin in the management of myalgia in temporomandibular disorders: are all injections equal?
Anwar H; Attard A; Green J; Elledge ROC
Br J Oral Maxillofac Surg; 2023 Jan; 61(1):89-93. PubMed ID: 36522255
[TBL] [Abstract][Full Text] [Related]
2. Botulinum Toxin for Treating Temporomandibular Disorders: What is the Evidence?
Delcanho R; Val M; Guarda Nardini L; Manfredini D
J Oral Facial Pain Headache; 2022; 36(1):6-20. PubMed ID: 35298571
[TBL] [Abstract][Full Text] [Related]
3. The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache.
Pihut M; Ferendiuk E; Szewczyk M; Kasprzyk K; Wieckiewicz M
J Headache Pain; 2016; 17():29. PubMed ID: 27011213
[TBL] [Abstract][Full Text] [Related]
4. Effect of multiple injections of botulinum toxin into painful masticatory muscles on bone density in the temporomandibular complex.
Raphael KG; Janal MN; Tadinada A; Santiago V; Sirois DA; Lurie AG
J Oral Rehabil; 2020 Nov; 47(11):1319-1329. PubMed ID: 32885475
[TBL] [Abstract][Full Text] [Related]
5. Assessing change in functional outcomes and quality of life in myogenic temporomandibular disorders undergoing botulinum toxin injection: A before and after comparison.
Hosgor H; Coskunses FM; Altindis S
J Stomatol Oral Maxillofac Surg; 2023 Sep; 124(4):101434. PubMed ID: 36914004
[TBL] [Abstract][Full Text] [Related]
6. Intramuscular botulinum toxin injection additional to arthrocentesis in the management of temporomandibular joint pain.
Ivask O; Leibur E; Akermann S; Tamme T; Voog-Oras Ü
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Oct; 122(4):e99-e106. PubMed ID: 27496577
[TBL] [Abstract][Full Text] [Related]
7. Improvement in quality of life after botulinum toxin injection for temporomandibular disorder.
Villa S; Raoul G; Machuron F; Ferri J; Nicot R
J Stomatol Oral Maxillofac Surg; 2019 Feb; 120(1):2-6. PubMed ID: 30385428
[TBL] [Abstract][Full Text] [Related]
8. Does Adjunctive Botulinum Toxin A Reduce Pain Scores When Combined With Temporomandibular Joint Arthroscopy for the Treatment of Concomitant Temporomandibular Joint Arthralgia and Myofascial Pain?
Thomas NJ; Aronovich S
J Oral Maxillofac Surg; 2017 Dec; 75(12):2521-2528. PubMed ID: 28500876
[TBL] [Abstract][Full Text] [Related]
9. Occlusal force characteristics of masseteric muscles after intramuscular injection of botulinum toxin A(BTX - A)for treatment of temporomandibular disorder.
Zhang LD; Liu Q; Zou DR; Yu LF
Br J Oral Maxillofac Surg; 2016 Sep; 54(7):736-40. PubMed ID: 27138229
[TBL] [Abstract][Full Text] [Related]
10. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
11. Unclear results for the use of botulinum toxin therapy for TMD pain.
Keenan JR
Evid Based Dent; 2015 Dec; 16(4):122. PubMed ID: 26680526
[TBL] [Abstract][Full Text] [Related]
12. Treatment of temporomandibular disorders with botulinum toxin.
Schwartz M; Freund B
Clin J Pain; 2002; 18(6 Suppl):S198-203. PubMed ID: 12569969
[TBL] [Abstract][Full Text] [Related]
13. Temporomandibular Disorder Patients Benefit From Intramuscular Botulinum Toxin Type a Injections.
Oksanen E; Männistö V; Kormi E; Vallioniemi H; Suojanen J
J Craniofac Surg; 2022 Jun; 33(4):1159-1161. PubMed ID: 34743162
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin in the management of temporomandibular disorders: a systematic review.
Thambar S; Kulkarni S; Armstrong S; Nikolarakos D
Br J Oral Maxillofac Surg; 2020 Jun; 58(5):508-519. PubMed ID: 32143934
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin therapy for temporomandibular joint disorders: a systematic review of randomized controlled trials.
Chen YW; Chiu YW; Chen CY; Chuang SK
Int J Oral Maxillofac Surg; 2015 Aug; 44(8):1018-26. PubMed ID: 25920597
[TBL] [Abstract][Full Text] [Related]
16. Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.
Yoshida K
Toxins (Basel); 2021 Aug; 13(9):. PubMed ID: 34564609
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of IncobotulinumtoxinA Injection on Myalgia and Arthralgia in Patients Undergoing Temporomandibular Joint Arthroscopy: A Randomized Controlled Trial.
Ângelo DF; Sanz D; Maffia F; Cardoso HJ
Toxins (Basel); 2023 Jun; 15(6):. PubMed ID: 37368677
[TBL] [Abstract][Full Text] [Related]
18. Localized myofascial pain responds better than referring myofascial pain to botulinum toxin injections.
Abboud WA; Hassin-Baer S; Joachim M; Givol N; Yahalom R
Int J Oral Maxillofac Surg; 2017 Nov; 46(11):1417-1423. PubMed ID: 28521968
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy of botulinum toxin type A for the treatment of habitual dislocation of the temporomandibular joint.
Fu KY; Chen HM; Sun ZP; Zhang ZK; Ma XC
Br J Oral Maxillofac Surg; 2010 Jun; 48(4):281-4. PubMed ID: 19665263
[TBL] [Abstract][Full Text] [Related]
20. Recurrent TMJ Dislocation Managed with Botulinum Toxin Type A Injections in a Pediatric Patient.
Stark TR; Perez CV; Okeson JP
Pediatr Dent; 2015; 37(1):65-9. PubMed ID: 25685976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
